Details for New Drug Application (NDA): 021019
✉ Email this page to a colleague
NDA 021019 describes COMPAZINE, which is a drug marketed by Glaxosmithkline and is included in seven NDAs. Additional details are available on the COMPAZINE profile page.
The generic ingredient in COMPAZINE is prochlorperazine. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the prochlorperazine profile page.
The generic ingredient in COMPAZINE is prochlorperazine. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the prochlorperazine profile page.
Summary for 021019
| Tradename: | COMPAZINE |
| Applicant: | Glaxosmithkline |
| Ingredient: | prochlorperazine maleate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 10MG BASE | ||||
| Approval Date: | Oct 6, 1999 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | EQ 15MG BASE | ||||
| Approval Date: | Oct 6, 1999 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
